Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
Disease Category: Depression
Location: United States, CA
Clinical research study of an investigational medication vs. placebo added to a
standard antidepressant treatment in persons with Major Depression.
A multicenter, randomized, double-blind, phase II, safety and efficacy study of
xxx vs. placebo in patients with Major Depressive Disorder who exhibit an
inadequate response to antidepressant therapy.
Length of study: up to 11 weeks
Number of office visits: up to 8 visits
Qualified participants will receive either investigational study medication or
placebo added to standard antidepressant. Participants will receive study related
care at no cost and will be compensated for time and travel.
Study inclusion/exclusion criteria
This study is enrolling individuals who:
- Read and understand English
- Meet criteria for Major Depressive Disorder
- Are 18 to 65 years old
- Have a current inadequate response to an antidepressant
- Are without serious health problems
- Do not have certain conditions such as Bipolar, Obsessive-Compulsive
Disorder, or Schizophrenia
- Do not have a recent drug
California Neuroscience Research Medical Group, Inc.
4835 Van Nuys Blvd., Suite 104
Sherman Oaks, CA 91403
Phone: (818) 990-2671
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these